{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T07:28:17Z","timestamp":1772954897958,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008524","name":"University of Montana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007234","name":"University of Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400050C"],"award-info":[{"award-number":["HHSN272201400050C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI160406"],"award-info":[{"award-number":["U01AI160406"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93023C00047"],"award-info":[{"award-number":["75N93023C00047"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jvacx.2025.100699","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T16:07:39Z","timestamp":1754582859000},"page":"100699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against Mycobacterium tuberculosis challenge in mice"],"prefix":"10.1016","volume":"26","author":[{"given":"Viktoria","family":"Rungelrath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushtaq","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibha","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Riffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid M.","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibali","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabaana A.","family":"Khader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay T.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jvacx.2025.100699_bb0005","article-title":"An overview of vaccine adjuvants: current evidence and future perspectives","volume":"10","author":"Facciol\u00e0","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.jvacx.2025.100699_bb0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jvacx.2025.100699_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.745016","article-title":"Exploration of pattern recognition receptor agonists as candidate adjuvants","volume":"11","author":"Ong","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.jvacx.2025.100699_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jvacx.2025.100699_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102172","article-title":"Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics","volume":"70","author":"Kaur","year":"2022","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jvacx.2025.100699_bb0030","doi-asserted-by":"crossref","first-page":"19570","DOI":"10.1038\/srep19570","article-title":"Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens","volume":"6","author":"Knudsen","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jvacx.2025.100699_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071455","article-title":"Using dual toll-like receptor Agonism to drive Th1-biased response in a squalene- and \u03b1-tocopherol-containing emulsion for a more effective SARS-CoV-2 vaccine","volume":"14","author":"Short","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jvacx.2025.100699_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020142","article-title":"TLR agonists as vaccine adjuvants targeting Cancer and infectious diseases","volume":"13","author":"Luchner","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jvacx.2025.100699_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020423","article-title":"Recent advances in the development of toll-like receptor agonist-based vaccine adjuvants for infectious diseases","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jvacx.2025.100699_bb0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jvacx.2025.100699_bb0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems","volume":"10","author":"Gar\u00e7on","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.jvacx.2025.100699_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","article-title":"From discovery to licensure, the adjuvant system story","volume":"13","author":"Gar\u00e7on","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jvacx.2025.100699_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-017-0027-3","article-title":"Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFN\u03b3 response promoting vaccine immunogenicity","volume":"2","author":"Coccia","year":"2017","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.jvacx.2025.100699_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071850","article-title":"Practical considerations for next-generation adjuvant development and translation","volume":"15","author":"Lykins","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jvacx.2025.100699_bb0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2019.02.009","article-title":"Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","volume":"59","author":"Heineman","year":"2019","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"10.1016\/j.jvacx.2025.100699_bb0080","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/infdis\/jiac327","article-title":"Safety and immunogenicity of a respiratory syncytial virus Prefusion F (RSVPreF3) candidate vaccine in older adults: phase 1\/2 randomized clinical trial","volume":"227","author":"Leroux-Roels","year":"2023","journal-title":"J Infect Dis"},{"issue":"9447","key":"10.1016\/j.jvacx.2025.100699_bb0085","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jvacx.2025.100699_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-023-00694-y","article-title":"A lipidated TLR7\/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice","volume":"8","author":"Miller","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.jvacx.2025.100699_bb0095","article-title":"Co-delivery of novel synthetic TLR4 and TLR7\/8 ligands adsorbed to aluminum salts promotes Th1-mediated immunity against poorly immunogenic SARS-CoV-2 RBD","volume":"12","author":"Siram","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.jvacx.2025.100699_bb0100","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.imbio.2011.06.005","article-title":"Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions","volume":"216","author":"Lang","year":"2011","journal-title":"Immunobiology"},{"issue":"7","key":"10.1016\/j.jvacx.2025.100699_bb0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nri.2016.55","article-title":"C-type lectin receptors in the control of T helper cell differentiation","volume":"16","author":"Geijtenbeek","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.jvacx.2025.100699_bb0110","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/mi.2016.70","article-title":"Subunit vaccine H56\/CAF01 induces a population of circulating CD4 T cells that traffic into the mycobacterium tuberculosis-infected lung","volume":"10","author":"Woodworth","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"12","key":"10.1016\/j.jvacx.2025.100699_bb0115","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstr\u00f8m","year":"2009","journal-title":"J Immunol"},{"issue":"52","key":"10.1016\/j.jvacx.2025.100699_bb0120","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"van Dissel","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jvacx.2025.100699_bb0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41541-024-00897-x","article-title":"Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses","volume":"9","author":"Rungelrath","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.jvacx.2025.100699_bb0130","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1021\/acsabm.4c00245","article-title":"Promotion of Th17 polarized immunity via co-delivery of Mincle agonist and tuberculosis antigen using silica nanoparticles","volume":"7","author":"Abdelwahab","year":"2024","journal-title":"ACS Appl Bio Mater"},{"issue":"11","key":"10.1016\/j.jvacx.2025.100699_bb0135","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.4049\/jimmunol.1600282","article-title":"Age-specific adjuvant synergy: dual TLR7\/8 and Mincle activation of human newborn dendritic cells enables Th1 polarization","volume":"197","author":"van Haren","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2025.100699_bb0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cyto.2017.08.009","article-title":"The synergistic effects of combining TLR ligand based adjuvants on the cytokine response are dependent upon p38\/JNK signalling","volume":"99","author":"Fischetti","year":"2017","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.jvacx.2025.100699_bb0145","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.0818-9641.2004.01280.x","article-title":"Adjuvant synergy: the effects of nasal coadministration of adjuvants","volume":"82","author":"Moschos","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.jvacx.2025.100699_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/vaccines2020297","article-title":"Vaccine potentiation by combination adjuvants","volume":"2","author":"Levast","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jvacx.2025.100699_bb0155","series-title":"Global Tuberculosis Report 2023","author":"Organization, W.H","year":"2023"},{"issue":"8986","key":"10.1016\/j.jvacx.2025.100699_bb0160","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jvacx.2025.100699_bb0165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3 Suppl","key":"10.1016\/j.jvacx.2025.100699_bb0170","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.2223\/JPED.1499","article-title":"BCG vaccine: efficacy and indications for vaccination and revaccination","volume":"82","author":"Barreto","year":"2006","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jvacx.2025.100699_bb0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cytogfr.2010.10.004","article-title":"IL-17 and Th17 cells in tuberculosis","volume":"21","author":"Torrado","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jvacx.2025.100699_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101431","article-title":"Key recent advances in TB vaccine development and understanding of protective immune responses against mycobacterium tuberculosis","volume":"50","author":"Scriba","year":"2020","journal-title":"Semin Immunol"},{"issue":"8","key":"10.1016\/j.jvacx.2025.100699_bb0185","article-title":"Next-generation TB vaccines: Progress, challenges, and prospects","volume":"11","author":"Zhuang","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jvacx.2025.100699_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117594","article-title":"Tuberculosis vaccine: a journey from BCG to present","volume":"252","author":"Fatima","year":"2020","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.jvacx.2025.100699_bb0195","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1473-3099(19)30625-5","article-title":"The status of tuberculosis vaccine development","volume":"20","author":"Schrager","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"25","key":"10.1016\/j.jvacx.2025.100699_bb0200","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01(E) vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2025.100699_bb0205","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fimmu.2020.00406","article-title":"Novel Lipidated Imidazoquinoline TLR7\/8 adjuvants elicit influenza-specific Th1 immune responses and protect against heterologous H3N2 influenza challenge in mice","volume":"11","author":"Miller","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvacx.2025.100699_bb0210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-230X(08)60912-4","article-title":"Criteria for analyzing interactions between biologically active agents","volume":"35","author":"Berenbaum","year":"1981","journal-title":"Adv Cancer Res"},{"issue":"2","key":"10.1016\/j.jvacx.2025.100699_bb0215","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/eji.201141569","article-title":"IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination","volume":"42","author":"Gopal","year":"2012","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.jvacx.2025.100699_bb0220","first-page":"712","article-title":"CXCR5+ T helper cells mediate protective immunity against tuberculosis","volume":"123","author":"Slight","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jvacx.2025.100699_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cyto.2014.02.001","article-title":"Human monocytes produce interferon-gamma upon stimulation with LPS","volume":"67","author":"Kraaij","year":"2014","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.jvacx.2025.100699_bb0230","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41423-022-00861-6","article-title":"Role of antibodies in vaccine-mediated protection against tuberculosis","volume":"19","author":"Dieli","year":"2022","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"10.1016\/j.jvacx.2025.100699_bb0235","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1462-5822.2008.01188.x","article-title":"Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages","volume":"10","author":"Ferwerda","year":"2008","journal-title":"Cell Microbiol"},{"issue":"2","key":"10.1016\/j.jvacx.2025.100699_bb0240","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/eji.200737741","article-title":"Syk kinase is required for collaborative cytokine production induced through Dectin-1 and toll-like receptors","volume":"38","author":"Dennehy","year":"2008","journal-title":"Eur J Immunol"},{"issue":"7\u20138","key":"10.1016\/j.jvacx.2025.100699_bb0245","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.micinf.2016.03.007","article-title":"Signalling through MyD88 drives surface expression of the mycobacterial receptors MCL (Clecsf8, Clec4d) and Mincle (Clec4e) following microbial stimulation","volume":"18","author":"Kerscher","year":"2016","journal-title":"Microbes Infect"},{"issue":"7","key":"10.1016\/j.jvacx.2025.100699_bb0250","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.4049\/jimmunol.1301593","article-title":"Differential control of Mincle-dependent cord factor recognition and macrophage responses by the transcription factors C\/EBP\u03b2 and HIF1\u03b1","volume":"193","author":"Schoenen","year":"2014","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jvacx.2025.100699_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20021229","article-title":"Mycobacteria target DC-SIGN to suppress dendritic cell function","volume":"197","author":"Geijtenbeek","year":"2003","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.jvacx.2025.100699_bb0260","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.celrep.2015.10.058","article-title":"Dectin-1 regulates hepatic fibrosis and Hepatocarcinogenesis by suppressing TLR4 signaling pathways","volume":"13","author":"Seifert","year":"2015","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.jvacx.2025.100699_bb0265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1189\/jlb.3A0515-185R","article-title":"Mincle suppresses toll-like receptor 4 activation","volume":"100","author":"Greco","year":"2016","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.jvacx.2025.100699_bb0270","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4049\/jimmunol.1601665","article-title":"Contact, collaboration, and conflict: signal integration of Syk-coupled C-type lectin receptors","volume":"198","author":"Ostrop","year":"2017","journal-title":"J Immunol"},{"issue":"38","key":"10.1016\/j.jvacx.2025.100699_bb0275","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1016\/j.vaccine.2023.07.061","article-title":"An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice","volume":"41","author":"Honda-Okubo","year":"2023","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jvacx.2025.100699_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201253","article-title":"Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves","volume":"13","author":"Thakur","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jvacx.2025.100699_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840225","article-title":"It takes a village: the multifaceted immune response to mycobacterium tuberculosis infection and vaccine-induced immunity","volume":"13","author":"Larsen","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jvacx.2025.100699_bb0290","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/CVI.00721-14","article-title":"Quest for correlates of protection against tuberculosis","volume":"22","author":"Bhatt","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jvacx.2025.100699_bb0295","doi-asserted-by":"crossref","first-page":"1260859","DOI":"10.3389\/fimmu.2023.1260859","article-title":"Early innate cell interactions with mycobacterium tuberculosis in protection and pathology of tuberculosis","volume":"14","author":"Sankar","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jvacx.2025.100699_bb0300","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/mi.2014.136","article-title":"Immune requirements for protective Th17 recall responses to mycobacterium tuberculosis challenge","volume":"8","author":"Monin","year":"2015","journal-title":"Mucosal Immunol"},{"issue":"2","key":"10.1016\/j.jvacx.2025.100699_bb0305","article-title":"Lung IL-17A-producing CD4(+) T cells correlate with protection after intrapulmonary vaccination with differentially Adjuvanted tuberculosis vaccines","volume":"12","author":"Stewart","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.jvacx.2025.100699_bb0310","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1164\/rccm.201208-1385OC","article-title":"Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72\/AS01 in south African adults","volume":"188","author":"Day","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jvacx.2025.100699_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007643","article-title":"A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates","volume":"15","author":"Rodo","year":"2019","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.jvacx.2025.100699_bb0320","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.0904013","article-title":"Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate","volume":"184","author":"Schoenen","year":"2010","journal-title":"J Immunol"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136225000932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136225000932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:43:00Z","timestamp":1772916180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136225000932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":64,"alternative-id":["S2590136225000932"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2025.100699","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against Mycobacterium tuberculosis challenge in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2025.100699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100699"}}